A New Era of Visual AIDS
We've redesigned the Visual AIDS Web gallery! Our new design enhances the outstanding artwork of Visual AIDS' members, adds new features, and is easier to navigate. To inaugurate the new Web design, Julia Bryan-Wilson curates the current online exhibition.
HIV in the U.S. Among Women of Color
Though women of color make up less than a quarter of the female population in the U.S., they account for more than three-quarters of all AIDS cases reported. Body Positive has more on the epidemic among minority women and women who have sex with women.
Where Have My Mitochondria Gone?
The topic of mitochondrial damage is gaining more and more press as a potential side effect of anti-HIV medication. But what exactly is mitochondrial damage and why should we care? Dr. Brad S. Lichtenstein explains.
The Body Covers the International AIDS Conference
Next month's XIV International AIDS Conference will focus not only on the latest research on HIV/AIDS, but also on less-clinical issues such as public policy and prevention programs. The Body's outstanding group of HIV specialists will be on hand to provide next-day coverage.
For a Puerto Rican Woman, HIV Has Its Blessings
"Because of all the support, therapy, doctors and medicine, I've become able to appreciate life on life's terms." A native Puerto Rican talks about how HIV has changed her -- for the better -- in "Breaking the Silence," a series of columns by HIV-positive Hispanic men and women.
New Drug Shows Promise vs. Resistant HIV
DPC 817 is a drug currently being studied that may be useful as a component of HAART regimens in individuals with resistance to older NRTIs.
The Drug-Price War: Can Anyone Win?
The storm clouds are darkening over the drug-pricing battlefield, as U.S. states arm themselves for what may become a gruesome, brutal war with the pharmaceutical industry -- a war that, no matter what, could cost the public dearly. GMHC Treatment Issues provides an excellent analysis of this very ugly situation.
Thousands Die Yearly From Lack of Insurance
The lack of health insurance in America leads to delayed diagnoses, life-threatening complications and, ultimately, 18,000 premature deaths each year, according to a report released by the Institute of Medicine.
"We Will Not Be Silenced"
Abstinence-only education, censorship of so-called "provocative"
material, anti-gay policies -- what effect is the puritanism of George W. and his fellow Republicans having on HIV prevention? Jim Pickett, an HIV-prevention advocate in Chicago, reveals the awful truth.
Alternate Ways to Lower Triglycerides
Flaxseed and fish oils have been found to help many people lower their triglyceride levels. Be warned, though: They're not a miracle solution. Dr. Brad Lichtenstein tells us more.
The Facts on STD Transmission
SIECUS provides an extensive fact sheet on STDs in the United States: who gets them, what they get, how STDs can be prevented, and where to turn for more information.
Do Clinical Trials Matter Anymore?
It's becoming more difficult for researchers to conduct effective clinical trials, and the people who those trials can help most -- minorities and the poor -- aren't signing up anyway. So why bother conducting them at all? STEP Perspective has an answer.
I Thought About You
A Selection of the Top HIV/AIDS Stories From Across the Internet
An online project to gather the memories of Barcelona residents and visitors who have lost loved ones to AIDS. The memories people submit will be displayed at next month's International AIDS Conference.
Molecular Weapon May Fight Off HIV
"Gene silencing" -- using RNA as a weapon -- shows promise, biologists report.
From San Francisco Chronicle (June 3, 2002)
Are Trends in HIV, Gonorrhoea, and Syphilis Worsening in Western Europe?
In short: yes, two key European health officials say.
From British Medical Journal (June 1, 2002)
Editorial: HIV Drug Resistance (PDF)
So much research has yet to be done on HIV drug resistance, says HIV
Clinical Trials' guest editor Dr. Jean-Claude Schmit.
From HIV Clinical Trials (May/June 2002)
NOTE: To read up on some of the resistance research that has been done thus far, read HIV Clinical Trials' special section on resistance to anti-HIV drugs.